{"id":"W1941265576","doi":"10.1007/s00280-015-2761-4","title":"A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck","year":2015,"lang":"en","type":"article","venue":"Cancer Chemotherapy and Pharmacology","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":30,"is_retracted":false,"has_abstract":false,"ca_institutions":"Centre d'expertise et de recherche en infrastructures urbaines","funders":"Symphogen; Merck KGaA","keywords":"Medicine; Tolerability; Cetuximab; Internal medicine; Epidermal growth factor receptor; Adverse effect; Oncology; Head and neck cancer; Antibody; Head and neck squamous-cell carcinoma; Monoclonal antibody; Gastroenterology; Cancer; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001219235,0.001102444,0.001701575,0.0004226074,0.0003632838,0.0008707867,0.0009301131,0.001411387,0.008989709],"category_scores_gemma":[0.001014158,0.0004380356,0.001461516,0.0003148723,0.0008241333,0.0009409228,0.0004101979,0.003232938,0.001134658],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001147906,"about_ca_system_score_gemma":0.001860291,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001002225,"about_ca_topic_score_gemma":0.003152256,"domain_scores_codex":[0.9996307,0.0001929367,0.00001455713,0.00005042936,0.00002960736,0.00008187078],"domain_scores_gemma":[0.9995868,0.0001307888,0.00004595553,0.00003507601,0.0000261864,0.000175122],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8647048,0.02724834,0.001408185,0.0006427395,0.0007545099,0.000194781,0.0001091889,0.001354302,0.01716412,0.000530642,0.002254751,0.08363355],"study_design_scores_gemma":[0.5477577,0.4411774,0.004081492,0.00003509539,0.000426486,0.0001178367,0.00007608067,0.0007927176,0.002460045,0.000257261,0.00279238,0.0000254753],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9906698,0.001579648,0.0007380165,0.0009378354,0.0004892718,0.001881999,0.0006081626,0.0001265057,0.002968744],"genre_scores_gemma":[0.9867203,0.002084835,0.001672612,0.0008455297,0.0002741446,0.001464908,0.001049272,0.00002542347,0.005862874],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008989709,"threshold_uncertainty_score":0.03007364,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0269664643091963,"score_gpt":0.3554148779356516,"score_spread":0.3284484136264553,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}